DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Kotsopoulos J, Lubinski J, Neuhausen SL. et al.
Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Gynecol Oncol 2006;
100 (01) 83-88
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.